<DOC>
	<DOC>NCT01211431</DOC>
	<brief_summary>The goal is to compare the quality of post-cesarean analgesia, the side effects and the incidence of residual scar pain obtained with intrathecal morphine (reference treatment) or with a continuous intra-wound solution including both ropivacain and diclofenac (experimental treatment).</brief_summary>
	<brief_title>Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<criteria>single, normally progressing pregancy term &gt; 36 weeks amenorrhea BMI between 20 and 25 kg/m^2 before pregnancy height between 55 and 90 kg cesarean section by JoelCohen or Pfannenstiel techniques patient has signed consent patient has social security coverage Multiple pregnancy pathological pregnancy: hypertension (&gt;140/90 mmHg found during the pregnancy), preeclampsia, gestational diabetes term &lt; 36 weeks amenorrhea nonpregnancy related maternal pathology (insufficiency) obesity (BMI &gt; 25 kg/m^2 before pregnancy) height &lt; 155 cm or &gt; 180 cm weight &lt; 55 kg or &gt; 90 kg patient refuses to sign consent surgical technique other than JoelCohen or Pfannenstiel hepatic insufficiency (prothrombin &lt; 60%) contraindications for rachianesthesia: infection, hemostasis problems (platelets &lt; 80.109/L, prothrombin &lt; 60%, TCA &gt; 40s) allergy to local anesthestics patient is participating in another study, or has participated in another study within the last 6 months patient is under any type of guardianship</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>cesarean section</keyword>
	<keyword>pain</keyword>
	<keyword>ropivacain</keyword>
	<keyword>diclofena</keyword>
	<keyword>morphine</keyword>
</DOC>